🇺🇸 FDA
Pipeline program

Three doses of low-dosage investigational sIPV, vaccinated within one-month interval between doses

PRO-sIPV-1001-1

Unknown mab completed

Quick answer

Three doses of low-dosage investigational sIPV, vaccinated within one-month interval between doses for Poliomyelitis is a Unknown program (mab) at SINOVAC BIOTECH LTD with 1 ClinicalTrials.gov record(s).

Program details

Company
SINOVAC BIOTECH LTD
Indication
Poliomyelitis
Phase
Unknown
Modality
mab
Status
completed

Clinical trials